Conversely, gain-of function experiments with recombinant ACE2, overexpression of ACE2, and Ang 1–7 supplementation have shown protective effects in multiple models of cardiovascular disease, including hypertension, diabetes, and heart failure [22]. Here, ACE2 is linked to hypertensive disorder.